Championing individualised neurointensive care
- Neurological examination
The RCTs of therapies in Neuro ICU have shown no effect on pt prognosis
So what do you do??
But it may be that we are not finding the solution/therapy due to the heterogeneity of TBI
A response to the Chestnut trial –
There is therefore an unsurprising degree of variation in how TBIs are managed.
- Outcome was more favourable in pts treated in aggressive centres
Multi Modal Monitoring (MMM)
Multimodal monitoring approach improves ability to detect hypoperfusion in the injured brain
New paradigm – quantitative brain function monitoring